Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population
Taylor Morrisette(University of Colorado Hospital), Jonathan A. Gutman(University of Colorado Denver), Maheen Z. Abidi(University of Colorado Denver), Stephanie Chase(Eastern Oregon University), Valida Bajrovic(University of Colorado Anschutz Medical Campus), Matthew A. Miller(University of Colorado Hospital), Jeffrey N. Kaiser(University of Colorado Hospital), Esther Benamu(University of Colorado Denver), Gerard R. Barber(University of Colorado Hospital), Scott W. Mueller, Douglas N. Fish(University of Montana), Jennifer Tobin, Amanda G. Van Matre
Cited by 38
Related Papers
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
|Cancer Discovery|2020|550
Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study
|Clinical Infectious Diseases|2020|407
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
|Annals of Oncology|2021|328